Edgewise Therapeutics, Inc. (EWTX) Reports In-Line Q4 EPS

Edgewise Therapeutics, Inc. (NASDAQ: EWTX) reported Q4 EPS of ($0.42), in-line with the analyst estimate of ($0.42).

For earnings history and earnings-related data on Edgewise Therapeutics, Inc. (EWTX) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Inhibrx, Inc. (INBX) Misses Q2 EPS by 54c
• Gemini Space Station, Inc. (GEMI) Misses Q2 EPS by 32c